SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-11-001025
Filing Date
2011-02-17
Accepted
2011-02-17 16:37:47
Documents
15
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2201820z10-k.htm 10-K 1620876
2 EX-10.49 a2201820zex-10_49.htm EX-10.49 16350
3 EX-10.50 a2201820zex-10_50.htm EX-10.50 12835
4 EX-21.1 a2201820zex-21_1.htm EX-21.1 5856
5 EX-23.1 a2201820zex-23_1.htm EX-23.1 4585
6 EX-31.1 a2201820zex-31_1.htm EX-31.1 13882
7 EX-31.2 a2201820zex-31_2.htm EX-31.2 13903
8 EX-32.1 a2201820zex-32_1.htm EX-32.1 8797
15 G107572.JPG g107572.jpg GRAPHIC 43993
  Complete submission text file 0001047469-11-001025.txt   14664993

Data Files

Seq Description Document Type Size
9 EX-101.INS vrtx-20101231.xml EX-101.INS 1517742
10 EX-101.SCH vrtx-20101231.xsd EX-101.SCH 116697
11 EX-101.CAL vrtx-20101231_cal.xml EX-101.CAL 112906
12 EX-101.LAB vrtx-20101231_lab.xml EX-101.LAB 1455340
13 EX-101.PRE vrtx-20101231_pre.xml EX-101.PRE 638257
14 EX-101.DEF vrtx-20101231_def.xml EX-101.DEF 404376
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19319 | Film No.: 11621339
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1